Cargando…

Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients

Statins are associated with a reduced risk of hepatocellular carcinoma (HCC) and have the potential to be an adjuvant agent for HCC. In this study, we examined whether statin use is associated with additional benefits among patients who received curative treatments (CTs) such as surgery, percutaneou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Li-Li, Hsieh, Mao-Chih, Chow, Jyh-Ming, Liu, Shing-Hwa, Chang, Chia-Lun, Wu, Szu-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023877/ https://www.ncbi.nlm.nih.gov/pubmed/27603355 http://dx.doi.org/10.1097/MD.0000000000004639

Ejemplares similares

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index
por: Chen, Jin-Hua, et al.
Publicado: (2016)

Cancer Risk in HBV Patients With Statin and Metformin Use: A Population-Based Cohort Study
por: Chen, Chang-I., et al.
Publicado: (2015)

Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment
por: Chen, Zhixian, et al.
Publicado: (2022)

Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan
por: Chen, Jin-Hua, et al.
Publicado: (2016)

Long-Term Survival in Patients With T2 Hepatocellular Carcinoma After Primary Curative Resection Can Be Further Stratified by Tumor Size
por: Ho, Cheng-Maw, et al.
Publicado: (2014)

Dementia Risk in Irradiated Patients With Head and Neck Cancer
por: Chen, Jin-Hua, et al.
Publicado: (2015)

HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case–control study
por: Li, Zhonghu, et al.
Publicado: (2016)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis
por: Lin, En-Kwang, et al.
Publicado: (2016)

The association of statin use and biochemical recurrence after curative treatment for prostate cancer: A systematic review and meta-analysis
por: Yin, Peng, et al.
Publicado: (2022)

The comparison of different antiviral therapies on the prognosis of hepatitis B virus-related hepatocellular carcinoma after curative treatments: A network meta-analysis
por: Xia, Zijing, et al.
Publicado: (2020)

The outcomes of therapeutic decision in lower 3rd rectal cancer patients
por: Chen, Chien-Hsin, et al.
Publicado: (2016)

Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan
por: Hsieh, Mao-Chih, et al.
Publicado: (2017)

Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based Study
por: Seo, Young-Seok, et al.
Publicado: (2016)

Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection
por: Wu, Ching-Yang, et al.
Publicado: (2015)

The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis
por: Sun, Chi, et al.
Publicado: (2017)

Clinicopathological and prognostic value of preoperative lymphocyte to monocyte ratio for hepatocellular carcinoma following curative resection: A meta-analysis including 4,092 patients
por: Lin, Shuwen, et al.
Publicado: (2021)

Shoulder Dysfunction After Radiotherapy in Surgically and Nonsurgically Treated Necks: A Prospective Study
por: Sun, Qiang, et al.
Publicado: (2015)

Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis
por: Que, Jenny, et al.
Publicado: (2020)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma
por: Li, Jiang, et al.
Publicado: (2023)

Radiotherapy Combined With Androgen Deprivation for Bone Oligometastases After Primary Curative Radiotherapy for Prostate Cancer: A Retrospective Study
por: Wu, Jun-Xin, et al.
Publicado: (2016)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA)
por: Liu, Rui, et al.
Publicado: (2015)

Successful management of the hepatocellular carcinoma with inferior vena cava tumor thrombus: A case report
por: Liu, Yuanjun, et al.
Publicado: (2021)

Challenges of BCLC stage C hepatocellular carcinoma: Results of a single-institutional experience on stereotactic body radiation therapy
por: Que, Jenny, et al.
Publicado: (2020)

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

The association between statin use and prognosis in esophageal cancer patients: A meta-analysis
por: Lv, Jing, et al.
Publicado: (2023)

Efficacy Comparison Between Total Laryngectomy and Nonsurgical Organ-Preservation Modalities in Treatment of Advanced Stage Laryngeal Cancer: A Meta-Analysis
por: Fu, Xiaoyuan, et al.
Publicado: (2016)

Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk
por: Li, Hong-Guang, et al.
Publicado: (2015)

Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma
por: Ji, Ren, et al.
Publicado: (2022)

Oxeiptosis core genes and their multi-omics analysis in hepatocellular carcinoma
por: Lin, Sen, et al.
Publicado: (2023)

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery
por: Shen, Tao, et al.
Publicado: (2017)

Association of TNIP1 polymorphisms with hepatocellular carcinoma in a Northwest Chinese Han population
por: Shi, Yuting, et al.
Publicado: (2021)

Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis
por: Peng, Jin-lin, et al.
Publicado: (2021)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE
por: Li, Yuxuan, et al.
Publicado: (2023)

350–560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacy
por: Zhao, Guang Sheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4ridlgsmg5is3gee01jm8ovgas